| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |